Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.intimp.2020.106885 http://scihub22266oqcxt.onion/10.1016/j.intimp.2020.106885 32795893!7414363!32795893     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+Immunopharmacol 2020 ; 88 (ä): 106885 Nephropedia Template TP {{tp|p=32795893|t=2020. Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments |pdf=|usr=}}{{32795893}} gab.com Text Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments JO: Int Immunopharmacol http://www.kidney.de/pget.php?&tw=1&pmid=32795893 #FOAvip The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to develop antiviral strategies for the treatment of COVID-19 are underway. The rapidly increasing understanding of SARS-CoV-2 virology provides a notable number of possible immunological procedures and drug targets. However, gaps remain in our understanding of the pathogenesis of COVID-19. In this review, we describe the latest information in the context of immunological approaches and emerging current antiviral strategies for COVID-19 treatment. Twit Text FOAVip Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments ????Int Immunopharmacol http://www.kidney.de/pget.php?&tw=1&pmid=32795893 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32795893 #FOAvip English Wikipedia <ref>{{Cite pmid|32795893}}</ref> Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments #MMPMID32795893 Goodarzi P; Mahdavi F; Mirzaei R; Hasanvand H; Sholeh M; Zamani F; Sohrabi M; Tabibzadeh A; Jeda AS; Niya MHK; Keyvani H; Karampoor S Int Immunopharmacol 2020[Nov]; 88 (ä): 106885 PMID32795893show ga The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to develop antiviral strategies for the treatment of COVID-19 are underway. The rapidly increasing understanding of SARS-CoV-2 virology provides a notable number of possible immunological procedures and drug targets. However, gaps remain in our understanding of the pathogenesis of COVID-19. In this review, we describe the latest information in the context of immunological approaches and emerging current antiviral strategies for COVID-19 treatment. |Animals[MESH] |Antibodies, Monoclonal/*therapeutic use[MESH] |Antibodies, Viral/blood[MESH] |Antiviral Agents/*therapeutic use[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Serotherapy[MESH] |Clinical Trials as Topic[MESH] |Coronavirus Infections/blood/*drug therapy/*immunology/therapy[MESH] |Humans[MESH] |Immunization, Passive[MESH] |Pandemics[MESH] |Pneumonia, Viral/blood/*drug therapy/*immunology[MESH] |SARS-CoV-2[MESH]Coronavirus disease 2019 (COVID-19): Immunological approaches and emer(epmc).pdf DeepDyve Pubget Overpricing